As a new analysis highlights the impact of skin tone on drug safety and efficacy, experts outline what can be done to make medical research more inclusive.
Soleno submitted the NDA to the FDA on June 27, 2024. The FDA accepted the NDA and granted Priority Review in August 2024. Diazoxide choline has been granted Breakthrough and Fast Track Designations ...